Further Information:

• Physical material: Polyglactin 910 (copolymer of glycolide and lactide).
• Construction: Braided (Monofilament in sizes 9/0 and 10/0).
• Absorbable / Non–absorbable: Absorbable.
• Coating (if applicable): 50% Polyglactin 370 and 50% Calcium Stearate.
• Tensile Strength (Wound Support): Medium Term (4 weeks).
• Absorption Time: Absorbed in 56–70 days, 63 days average.
• Frequent Uses: General soft tissue approximation and/or ligation, including use in Ophthalmic procedures.

Specification:

Tensile Strength Retention in Tissue:

75% of original strength remains at 2 weeks
50% of original strength remains at 3 weeks
25% of original strength remains at 4 weeks

Vicryl™ Plus Sutures with Irgacare^® MP (triclosan) are effective against the pathogens most commonly associated with surgical site infections:¹²³
• Staphylococcus aureus
• Staphylococcus epidermidis
• Methicillin–resistant Staphylococcus aureus (MRSA)
• Methicillin–resistant Staphylococcus aureusepidermidis (MRSE)

¹ Wang ZX, Jiang CP, Cao Y, Ding DT. Systematic Review and meta–analysis of triclosan–coated sutures for the prevention of surgical site infection. British Journal of Surgery 2013:100:465–473
² Edmiston CE, Daoud FC, Leaper D. Is there an evidence–based argument for embracing an antimicrobial (triclosan) coated suture technology to reduce the risk for surgical site infections?: A meta–analysis. Surgery 2103:154;89–100
³ Coated VICRYL Plus IFU (instructions for use)